Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: This study investigated how changes in metabolic syndrome (MetS) are associated with the subsequent risk of breast and endometrial cancer according to menopausal status. METHODS: This cohort study, using data from the National Health Insurance Service database, included women aged ≥40 years who underwent 2 biennial cancer screenings (2009-2010 and 2011-2012) and were followed up until 2020. Participants were grouped into MetS-free, MetS-recovery, MetS-development, and MetS-persistent groups. Menopausal status (premenopausal, perimenopausal, and postmenopausal) was assessed at 2 screenings. Cox proportional hazard regression was used to assess the association between MetS changes and cancer risk. RESULTS: In 3,031,980 women, breast and endometrial cancers were detected in 39,184 and 4,298, respectively. Compared with the MetS-free group, those who recovered, developed, or had persistent MetS showed an increased risk of breast cancer, with adjusted hazard ratios (aHRs) of 1.05, 1.05, and 1.11, respectively (p<0.005). MetS persistence was associated with an increased risk of breast cancer in postmenopausal women (aHR, 1.12, 95% confidence interval [CI], 1.08 to 1.16) but not in premenopausal or perimenopausal women. MetS persistence was associated with an increased risk of endometrial cancer in premenopausal, perimenopausal, and postmenopausal women, with aHRs of 1.41 (95% CI, 1.17 to 1.70), 1.59 (95% CI, 1.19 to 2.12), and 1.47 (95% CI, 1.32 to 1.63), respectively. CONCLUSIONS: Increased breast cancer risk was associated with recovered, developed, and persistent MetS in postmenopausal women. Meanwhile, increased endometrial cancer risk was found in obese women who recovered from MetS or persistently had MetS, regardless of menopausal status, when compared to MetS-free women.
Abstract
OBJECTIVES: This study investigated how changes in metabolic syndrome (MetS) are associated with the subsequent risk of breast and endometrial cancer according to menopausal status. METHODS: This cohort study, using data from the National Health Insurance Service database, included women aged ≥40 years who underwent 2 biennial cancer screenings (2009-2010 and 2011-2012) and were followed up until 2020. Participants were grouped into MetS-free, MetS-recovery, MetS-development, and MetS-persistent groups. Menopausal status (premenopausal, perimenopausal, and postmenopausal) was assessed at 2 screenings. Cox proportional hazard regression was used to assess the association between MetS changes and cancer risk. RESULTS: In 3,031,980 women, breast and endometrial cancers were detected in 39,184 and 4,298, respectively. Compared with the MetS-free group, those who recovered, developed, or had persistent MetS showed an increased risk of breast cancer, with adjusted hazard ratios (aHRs) of 1.05, 1.05, and 1.11, respectively (p<0.005). MetS persistence was associated with an increased risk of breast cancer in postmenopausal women (aHR, 1.12, 95% confidence interval [CI], 1.08 to 1.16) but not in premenopausal or perimenopausal women. MetS persistence was associated with an increased risk of endometrial cancer in premenopausal, perimenopausal, and postmenopausal women, with aHRs of 1.41 (95% CI, 1.17 to 1.70), 1.59 (95% CI, 1.19 to 2.12), and 1.47 (95% CI, 1.32 to 1.63), respectively. CONCLUSIONS: Increased breast cancer risk was associated with recovered, developed, and persistent MetS in postmenopausal women. Meanwhile, increased endometrial cancer risk was found in obese women who recovered from MetS or persistently had MetS, regardless of menopausal status, when compared to MetS-free women.
참고문헌 (41)
- Grundy SM, "Metabolic syndrome pandemic", Arterioscler Thromb Vasc Biol, 28, pp.629~636 (2008)
- Yoonjung Kim, "Trends in the prevalence and management of major metabolic risk factors for chronic disease over 20 years: Findings from the 1998–2018 Korea National Health and Nutrition Examination Survey", Epidemiology and Health, 43, pp.1~12 (2021), 한국역학회[DOI]
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- 강상율, "Breast Cancer Statistics in Korea, 2018", Journal of Breast Cancer, 24(2), pp.123~137 (2021), 한국유방암학회[DOI]
- Youjin Hong, "Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older", 예방의학회지, 55(6), pp.529~538 (2022), 대한예방의학회
- 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
- 강미주, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019", Cancer Research and Treatment, 54(2), pp.330~344 (2022), 대한암학회[DOI]
- Esposito K, "Metabolic syndrome and endometrial cancer : a meta-analysis", Endocrine, 45, pp.28~36 (2014)
- Yang X, "The role of metabolic syndrome in endometrial cancer : a review", Front Oncol, 9, pp.744~ (2019)
- Esposito K, "Metabolic syndrome and risk of cancer : a systematic review and meta-analysis", Diabetes Care, 35, pp.2402~2411 (2012)
- Hallajzadeh J, "Metabolic syndrome and its components in premenopausal and postmenopausal women : a comprehensive systematic review and meta-analysis on observational studies", Menopause, 25, pp.1155~1164 (2018)
- Cao Z, "Association of obesity status and metabolic syndrome with site-specific cancers : a population-based cohort study", Br J Cancer, 123, pp.1336~1344 (2020)
- Zhao P, "The metabolic syndrome is a risk factor for breast cancer : a systematic review and meta-analysis", Obes Facts, 13, pp.384~396 (2020)
- Premenopausal Breast Cancer Collaborative Group, "Association of body mass index and age with subsequent breast cancer risk in premenopausal women", JAMA Oncol, 4, pp.e181771~ (2018)
- Neuhouser ML, "Overweight, obesity, and postmenopausal invasive breast cancer risk : a secondary analysis of the women’s health initiative randomized clinical trials", JAMA Oncol, 1, pp.611~621 (2015)
- Zhang Y, "The association between metabolic abnormality and endometrial cancer : a large case-control study in China", Gynecol Oncol, 117, pp.41~46 (2010)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association", National Heart, Lung, and Blood Institute scientific statement : executive summary, 2005, pp.4, 198~203
- Kim S, "Impact of the policy of expanding benefit coverage for cancer patients on catastrophic health expenditure across different income groups in South Korea", Soc Sci Med, 138, pp.241~247 (2015)
- 양민수, "Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea", Cancer Research and Treatment, 54(2), pp.352~361 (2022), 대한암학회[DOI]
- "The Asia-Pacific perspective: redefining obesity and its treatment" (2000)[URL]
- Hwang KT, "Influence of metabolic syndrome on risk of breast cancer : a study analyzing nationwide data from Korean National Health Insurance Service", Cancer Epidemiol Biomarkers Prev, 29, pp.2038~2047 (2020)
- Choi IY, "Changes in metabolic syndrome status and breast cancer risk: a nationwide cohort study", Cancers(Basel), 13, pp.1177~ (2021)
- Engin A, "The definition and prevalence of obesity and metabolic syndrome", Adv Exp Med Biol, 960, pp.1~17 (2017)
- Moore LL, "Metabolic health reduces risk of obesity-related cancer in Framingham study adults", Cancer Epidemiol Biomarkers Prev, 23, pp.2057~2065 (2014)
- Kabat GC, "Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women", Cancer Epidemiol Biomarkers Prev, 26, pp.1730~1735 (2017)
- Park YM, "The association between metabolic health, obesity phenotype and the risk of breast cancer", Int J Cancer, 140, pp.2657~2666 (2017)
- Wang L, "Association between metabolic syndrome and endometrial cancer risk: a systematic review and meta-analysis of observational studies", Aging(Albany NY), 12, pp.9825~9839 (2020)
- Friedenreich CM, "Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer", Cancer Epidemiol Biomarkers Prev, 20, pp.2384~2395 (2011)
- Boyoung Park, "Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women", Journal of Gynecologic Oncology, 33(4), pp.1~13 (2022), 대한부인종양학회[DOI]
- Shoff SM, "Diabetes, body size, and risk of endometrial cancer", Am J Epidemiol, 148, pp.234~240 (1998)
- 임명철, "Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015", Journal of Gynecologic Oncology, 30(1), pp.1~8 (2019), 대한부인종양학회[DOI]
- Smith RA, "American Cancer Society guidelines for the early detection of cancer : update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also : update 2001--testing for early lung cancer detection", CA Cancer J Clin, 51, pp.38~75 (2001)
- Setiawan VW, "Type I and II endometrial cancers: have they different risk factors?", J Clin Oncol, 31, pp.2607~2618 (2013)
- Pfeiffer RM, "Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older : derivation and validation from population-based cohort studies", PLoS Med, 10, pp.e1001492~ (2013)
- Stern T, "Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?", Gynecol Oncol Rep, 38, pp.100863~ (2021)
- Hauner D, "Metabolic syndrome and breast cancer: is there a link?", Breast Care, 9, pp.277~281 (2014)
- Bjørge T, "Metabolic syndrome and endometrial carcinoma", Am J Epidemiol, 171, pp.892~902 (2010)
- Lindemann K, "Serum lipids and endometrial cancer risk : results from the HUNT-II study", Int J Cancer, 124, pp.2938~2941 (2009)
- 박수경, "한국인에서 유방암의 역학적 특성", 대한의사협회지, 62(8), pp.424~436 (2019), 대한의사협회